Business
Coherus BioSciences to Report First Quarter 2022 Financial Results on May 5th, 2022
REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter 2022
About this update from Coherus Oncology, Inc.
[{"type":"text","content":" REDWOOD CITY, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that its first quarter 2022 financial results will be released after the close of the United States financial markets on Thursday, May 5th, 2022. Starting at 4:30 p.m. ET, Coherus’ management team will host a conference call and webcast to discuss financial results and provide a general business update. After releasing first quarter 2022 financial results, the Company will post them on the Coherus website at https://investors.coherus.com. Conference Call InformationWhen: Thursday, May 5th, 2022, starting at 5 p.m. ETDial-in: (844) 452-6826 (Toll-Free U.S. and Canada) or (765) 507-2587 (International)Conference ID: 4142969 Webcast: https://investors.coherus.com/upcoming-events Please dial-in 15 minutes early to ensure a timely connection to the call. A replay of the webcast will be archived on the Coherus website for 30 days. Coherus Contact Information:McDavid StilwellChief Financial OfficerCoherus BioSciences, [email protected] \nSource: Coherus BioSciences, Inc.","length":2936,"tagName":"div"}]